CMA
BSX icon

Cedar Mountain Advisors’s Boston Scientific BSX Stock Holding History

Cedar Mountain Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$555 Hold
13
– – ﹤0.01% 1034
2026
Q1 		$816 Hold
13
– – ﹤0.01% 944
2025
Q4 		$1.24K Hold
13
– – ﹤0.01% 471
2025
Q3 		$1.27K Buy
+13
New +$1.35K ﹤0.01% 485
2024
Q3 		– Sell
-66
Closed -$5.08K – 339
2024
Q2 		$5.08K Hold
66
– – ﹤0.01% 230
2024
Q1 		$4.52K Buy
+66
New +$4.24K ﹤0.01% 236

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Cedar Mountain Advisors's BSX Position: Q2 2026 in Review

Cedar Mountain Advisors held its Boston Scientific (BSX) position steady in Q2 2026 at 13 shares worth $555. The position accounts for ﹤0.01% of the portfolio, ranked #1034.

Cedar Mountain Advisors first reported a position in BSX in Q1 2024 and has held it in 6 quarters since. The position peaked at $5.08K in Q2 2024. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Cedar Mountain Advisors held 13 shares of Boston Scientific worth $555 as of Q2 2026.
  • Cedar Mountain Advisors left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up ﹤0.01% of Cedar Mountain Advisors's portfolio in Q2 2026, its #1034 holding.
  • Cedar Mountain Advisors first reported a position in Boston Scientific in Q1 2024 and has held it in 6 quarters since.
  • Cedar Mountain Advisors's Boston Scientific position peaked at $5.08K in Q2 2024.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Cedar Mountain Advisors's 13F filing for Q2 2026, filed 2 Jul 2026.